ResMed Inc. logo

ResMed Inc.

RMD | NYSE
Chart Builder DCF Calculator
$224.71
+$1.10 (+0.49%)
Sep 22, 2026, 11:19 AM ET · Market open
Fiscal Year
Period Ending
FY 2026
Jun 29, 2026
FY 2025
Jun 29, 2025
FY 2024
Jun 29, 2024
FY 2023
Jun 29, 2023
FY 2022
Jun 29, 2022
FY 2021
Jun 29, 2021
Revenue
5.65B 5.15B 4.69B 4.22B 3.58B 3.2B
Cost of Revenue
2.2B 2.09B 2.03B 1.87B 1.55B 1.36B
Gross Profit
3.46B 3.05B 2.66B 2.36B 2.02B 1.84B
Operating Income
1.89B 1.69B 1.32B 1.13B 1B 903.68M
Interest Income
n/a n/a n/a n/a n/a 362K
Pretax Income
1.92B 1.68B 1.26B 1.1B 960.48M 883.66M
Net Income
1.52B 1.4B 1.02B 897.56M 779.44M 474.51M
Selling & General & Admin
817.39M 991.02M 917.14M 874M 739.37M 670.39M
Research & Development
378.29M 331.28M 307.53M 287.64M 253.58M 225.28M
Other Expenses
369.35M 47.3M 110.75M 62.15M 31.08M 39.75M
Operating Expenses
1.57B 1.37B 1.34B 1.22B 1.02B 935.42M
Interest Expense
29.03M 12.61M 45.71M 47.38M 22.31M 23.99M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a
Cost & Expenses
3.76B 3.46B 3.37B 3.09B 2.58B 2.29B
Income Tax Expense
396.12M 276.84M 243.85M 204.11M 181.05M 409.16M
Shares Outstanding (Basic)
144.71M 146.72M 147.02M 146.77M 146.07M 145.31M
Shares Outstanding (Diluted)
144.98M 147.34M 147.55M 147.46M 147.04M 146.45M
EPS (Basic)
10.44 9.55 6.94 6.12 5.34 3.27
EPS (Diluted)
10.40 9.51 6.92 6.09 5.30 3.24
EBITDA
2.15B 1.91B 1.53B 1.36B 1.18B 1.1B
EBIT
1.95B 1.68B 1.31B 1.16B 982.8M 912.35M
Depreciation & Amortization
197.86M 235.81M 216.21M 196.52M 193.84M 191.52M

© 2026 bestshares.com. All rights reserved.